ID   SYNE3_HUMAN             Reviewed;         975 AA.
AC   Q6ZMZ3; A6H8H3; Q86SX5; Q8N7G8;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   07-APR-2021, entry version 141.
DE   RecName: Full=Nesprin-3;
DE   AltName: Full=KASH domain-containing protein 3;
DE            Short=KASH3;
DE   AltName: Full=Nuclear envelope spectrin repeat protein 3;
GN   Name=SYNE3 {ECO:0000312|HGNC:HGNC:19861};
GN   Synonyms=C14orf139 {ECO:0000312|HGNC:HGNC:19861},
GN   C14orf49 {ECO:0000312|HGNC:HGNC:19861},
GN   LINC00341 {ECO:0000312|HGNC:HGNC:19861};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=B-cell;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS MET-668
RP   AND LEU-795 DEL.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 41-975 (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 411-975 (ISOFORM 1), AND VARIANTS MET-668
RP   AND VAL-923.
RC   TISSUE=Synovial cell, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=16330710; DOI=10.1083/jcb.200506083;
RA   Wilhelmsen K., Litjens S.H.M., Kuikman I., Tshimbalanga N., Janssen H.,
RA   van den Bout I., Raymond K., Sonnenberg A.;
RT   "Nesprin-3, a novel outer nuclear membrane protein, associates with the
RT   cytoskeletal linker protein plectin.";
RL   J. Cell Biol. 171:799-810(2005).
RN   [6]
RP   FUNCTION, DOMAIN, AND INTERACTION WITH SUN1 AND SUN2.
RX   PubMed=18396275; DOI=10.1016/j.yexcr.2008.02.022;
RA   Stewart-Hutchinson P.J., Hale C.M., Wirtz D., Hodzic D.;
RT   "Structural requirements for the assembly of LINC complexes and their
RT   function in cellular mechanical stiffness.";
RL   Exp. Cell Res. 314:1892-1905(2008).
RN   [7]
RP   INTERACTION WITH TOR1A.
RX   PubMed=18827015; DOI=10.1242/jcs.029454;
RA   Nery F.C., Zeng J., Niland B.P., Hewett J., Farley J., Irimia D., Li Y.,
RA   Wiche G., Sonnenberg A., Breakefield X.O.;
RT   "TorsinA binds the KASH domain of nesprins and participates in linkage
RT   between nuclear envelope and cytoskeleton.";
RL   J. Cell Sci. 121:3476-3486(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21937718; DOI=10.1091/mbc.e11-04-0287;
RA   Morgan J.T., Pfeiffer E.R., Thirkill T.L., Kumar P., Peng G.,
RA   Fridolfsson H.N., Douglas G.C., Starr D.A., Barakat A.I.;
RT   "Nesprin-3 regulates endothelial cell morphology, perinuclear cytoskeletal
RT   architecture, and flow-induced polarization.";
RL   Mol. Biol. Cell 22:4324-4334(2011).
RN   [10]
RP   INTERACTION WITH SYNE1.
RX   PubMed=22518138; DOI=10.1155/2012/736524;
RA   Taranum S., Sur I., Muller R., Lu W., Rashmi R.N., Munck M., Neumann S.,
RA   Karakesisoglou I., Noegel A.A.;
RT   "Cytoskeletal interactions at the nuclear envelope mediated by nesprins.";
RL   Int. J. Cell Biol. 2012:736524-736524(2012).
CC   -!- FUNCTION: As a component of the LINC (LInker of Nucleoskeleton and
CC       Cytoskeleton) complex involved in the connection between the nuclear
CC       lamina and the cytoskeleton. The nucleocytoplasmic interactions
CC       established by the LINC complex play an important role in the
CC       transmission of mechanical forces across the nuclear envelope and in
CC       nuclear movement and positioning. Probable anchoring protein which
CC       tethers the nucleus to the cytoskeleton by binding PLEC which can
CC       associate with the intermediate filament system. Plays a role in the
CC       regulation of aortic epithelial cell morphology, and is required for
CC       flow-induced centrosome polarization and directional migration in
CC       aortic endothelial cells. {ECO:0000269|PubMed:16330710,
CC       ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:21937718}.
CC   -!- SUBUNIT: Core component of LINC complexes which are composed of inner
CC       nuclear membrane SUN domain-containing proteins coupled to outer
CC       nuclear membrane KASH domain-containing nesprins. SUN and KASH domain-
CC       containing proteins seem to bind each other promiscuously; however,
CC       differentially expression of LINC complex constituents can give rise to
CC       specific assemblies. Interacts with SUN1 and SUN2; probably forming
CC       respective LINC complexes. Interacts with PLEC (via actin-binding
CC       domain). Interacts with DST. Interacts with SYNE1 via spectrin repeats.
CC       Interacts (via KASH domain) with TOR1A (ATP-bound); the interaction is
CC       required for SYNE3 nuclear envelope localization.
CC       {ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:18827015,
CC       ECO:0000269|PubMed:22518138}.
CC   -!- INTERACTION:
CC       Q6ZMZ3-1; Q6ZWR6-5: Syne1; Xeno; NbExp=2; IntAct=EBI-10760907, EBI-10760805;
CC   -!- SUBCELLULAR LOCATION: Nucleus outer membrane
CC       {ECO:0000269|PubMed:21937718}; Single-pass type IV membrane protein
CC       {ECO:0000269|PubMed:21937718}. Nucleus envelope
CC       {ECO:0000269|PubMed:21937718}. Rough endoplasmic reticulum
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q6ZMZ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZMZ3-2; Sequence=VSP_023978;
CC       Name=3;
CC         IsoId=Q6ZMZ3-3; Sequence=VSP_023976, VSP_023977;
CC   -!- TISSUE SPECIFICITY: Expressed in aortic endothelial cells (at protein
CC       level). {ECO:0000269|PubMed:21937718}.
CC   -!- DOMAIN: The KASH domain is involved in the binding to SUN1 and SUN2
CC       through recognition of their SUN domains.
CC       {ECO:0000269|PubMed:18396275}.
CC   -!- PTM: The disulfid bond with SUN1 or SUN2 is required for stability of
CC       the respective LINC complex under tensile forces.
CC       {ECO:0000250|UniProtKB:Q8WXH0}.
CC   -!- SIMILARITY: Belongs to the nesprin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC05312.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAD18582.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAD62365.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX248076; CAD62365.1; ALT_INIT; mRNA.
DR   EMBL; AL138539; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146604; AAI46605.1; -; mRNA.
DR   EMBL; AK098471; BAC05312.1; ALT_INIT; mRNA.
DR   EMBL; AK131436; BAD18582.1; ALT_INIT; mRNA.
DR   CCDS; CCDS86430.1; -. [Q6ZMZ3-2]
DR   CCDS; CCDS9935.1; -. [Q6ZMZ3-1]
DR   RefSeq; NP_689805.3; NM_152592.4. [Q6ZMZ3-1]
DR   RefSeq; XP_005267434.1; XM_005267377.3.
DR   RefSeq; XP_006720126.1; XM_006720063.3. [Q6ZMZ3-1]
DR   RefSeq; XP_016876545.1; XM_017021056.1.
DR   PDB; 6WME; X-ray; 1.53 A; B=948-975.
DR   PDBsum; 6WME; -.
DR   SMR; Q6ZMZ3; -.
DR   BioGRID; 127775; 8.
DR   IntAct; Q6ZMZ3; 1.
DR   STRING; 9606.ENSP00000334308; -.
DR   CarbonylDB; Q6ZMZ3; -.
DR   iPTMnet; Q6ZMZ3; -.
DR   PhosphoSitePlus; Q6ZMZ3; -.
DR   SwissPalm; Q6ZMZ3; -.
DR   BioMuta; SYNE3; -.
DR   DMDM; 134035037; -.
DR   EPD; Q6ZMZ3; -.
DR   jPOST; Q6ZMZ3; -.
DR   MassIVE; Q6ZMZ3; -.
DR   MaxQB; Q6ZMZ3; -.
DR   PaxDb; Q6ZMZ3; -.
DR   PeptideAtlas; Q6ZMZ3; -.
DR   PRIDE; Q6ZMZ3; -.
DR   ProteomicsDB; 67943; -. [Q6ZMZ3-1]
DR   ProteomicsDB; 67944; -. [Q6ZMZ3-2]
DR   ProteomicsDB; 67945; -. [Q6ZMZ3-3]
DR   Antibodypedia; 54248; 155 antibodies.
DR   Ensembl; ENST00000334258; ENSP00000334308; ENSG00000176438. [Q6ZMZ3-1]
DR   Ensembl; ENST00000553340; ENSP00000450774; ENSG00000176438. [Q6ZMZ3-3]
DR   Ensembl; ENST00000557275; ENSP00000450562; ENSG00000176438. [Q6ZMZ3-2]
DR   GeneID; 161176; -.
DR   KEGG; hsa:161176; -.
DR   UCSC; uc001yei.4; human. [Q6ZMZ3-1]
DR   CTD; 161176; -.
DR   DisGeNET; 161176; -.
DR   GeneCards; SYNE3; -.
DR   HGNC; HGNC:19861; SYNE3.
DR   HPA; ENSG00000176438; Tissue enhanced (adipose tissue, bone marrow).
DR   MIM; 610861; gene.
DR   neXtProt; NX_Q6ZMZ3; -.
DR   OpenTargets; ENSG00000176438; -.
DR   PharmGKB; PA134931380; -.
DR   VEuPathDB; HostDB:ENSG00000176438.12; -.
DR   eggNOG; ENOG502QQSI; Eukaryota.
DR   GeneTree; ENSGT00440000039367; -.
DR   HOGENOM; CLU_012764_0_0_1; -.
DR   InParanoid; Q6ZMZ3; -.
DR   OMA; RDIKAQW; -.
DR   OrthoDB; 87219at2759; -.
DR   PhylomeDB; Q6ZMZ3; -.
DR   TreeFam; TF331132; -.
DR   PathwayCommons; Q6ZMZ3; -.
DR   BioGRID-ORCS; 161176; 2 hits in 988 CRISPR screens.
DR   ChiTaRS; SYNE3; human.
DR   GenomeRNAi; 161176; -.
DR   Pharos; Q6ZMZ3; Tbio.
DR   PRO; PR:Q6ZMZ3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q6ZMZ3; protein.
DR   Bgee; ENSG00000176438; Expressed in tendon of biceps brachii and 226 other tissues.
DR   ExpressionAtlas; Q6ZMZ3; baseline and differential.
DR   Genevisible; Q6ZMZ3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0034993; C:meiotic nuclear membrane microtubule tethering complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005640; C:nuclear outer membrane; IBA:GO_Central.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; IMP:UniProtKB.
DR   GO; GO:0140444; F:cytoskeleton-nuclear membrane anchor activity; IDA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0090150; P:establishment of protein localization to membrane; IDA:UniProtKB.
DR   GO; GO:0007097; P:nuclear migration; IBA:GO_Central.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   InterPro; IPR012315; KASH.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   InterPro; IPR030267; SYNE3.
DR   PANTHER; PTHR47535:SF2; PTHR47535:SF2; 1.
DR   Pfam; PF10541; KASH; 1.
DR   Pfam; PF00435; Spectrin; 1.
DR   SMART; SM01249; KASH; 1.
DR   SMART; SM00150; SPEC; 3.
DR   PROSITE; PS51049; KASH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Disulfide bond;
KW   Endoplasmic reticulum; Membrane; Nucleus; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..975
FT                   /note="Nesprin-3"
FT                   /id="PRO_0000281120"
FT   TOPO_DOM        1..925
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00385"
FT   TRANSMEM        926..946
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00385"
FT   TOPO_DOM        947..975
FT                   /note="Perinuclear space"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00385"
FT   REPEAT          220..325
FT                   /note="Spectrin 1"
FT   REPEAT          647..740
FT                   /note="Spectrin 2"
FT   DOMAIN          917..975
FT                   /note="KASH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00385"
FT   COILED          617..645
FT                   /evidence="ECO:0000255"
FT   DISULFID        953
FT                   /note="Interchain (C-563 in SUN2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WXH0"
FT   DISULFID        953
FT                   /note="Interchain (with C-657 in SUN1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8WXH0"
FT   VAR_SEQ         593..596
FT                   /note="GLQE -> VRGL (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_023976"
FT   VAR_SEQ         597..975
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_023977"
FT   VAR_SEQ         793..797
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_023978"
FT   VARIANT         668
FT                   /note="T -> M (in dbSNP:rs9671369)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031231"
FT   VARIANT         795
FT                   /note="Missing (in dbSNP:rs76499929)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_068433"
FT   VARIANT         864
FT                   /note="R -> H (in dbSNP:rs17092216)"
FT                   /id="VAR_031232"
FT   VARIANT         923
FT                   /note="A -> V (in dbSNP:rs12434757)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_031233"
FT   VARIANT         946
FT                   /note="I -> V (in dbSNP:rs10130647)"
FT                   /id="VAR_031234"
SQ   SEQUENCE   975 AA;  112216 MW;  A409AF86E1E781F4 CRC64;
     MTQQPQDDFD RSVEDAQAWM KAVQDQLQVN DNTQGPRAAL EARLWETEKI CQLEPEGRVR
     VDLVLRMAEA LLACCPGDQK PGILARLKDI KAQWEETVTY MTHCHSRIEW VWLHWSEYLL
     ARDEFYRWFQ KMMVTLEPHI ELQLGLKEKQ WQLSHAQVLL HNVDNQAVLL DRLLEEAASL
     FNRIGDPSVD EDAQKRMKAE YDAVKAKAQK RVDLLEQVAR EHEEYQAGVD EFQLWLKAVV
     EKVNGCLGRN CKLPITQRLS TLQDIAKDFP RGEESLETLE EQSAGVIRNT SPLGAEKITG
     ELEEMRKVLE KLRALWEEEE ERLRGLLRSR GAWEQQIKQL EAELSEFRMV LQRLAQEGLQ
     PAAKAGTEDE LVAHWRRYSA TRAALASEEP RVDRLQAQLK ELIVFPHNLK PLSDSVIATI
     QEYQSLKVKS ARLRNAAAVE LWQHFQRPLQ DLQLWKALAQ RLLEVTASLP DLPSLHTFLP
     QIEAALMESS RLKELLTMLQ LKKDLLIGIF GQERATALLE QVAGSMRDRD LLHNSLLQRK
     SKLQSLLAQH KDFGAAFEPL QRKLLDLQVR VQAEKGLQRD LPGKQAQLSR LQGLQEEGLD
     LGAQMEAARP LVQENPNHQH KMDQLSSDFQ ALQRSLEDLV DRCRQSVQEH CTFSHQLLEL
     RQWIVVTTQK LEAHRGEAGP GDAESQEAEF ERLVAEFPEK EAQLSLVEAQ GWLVMEKSSP
     EGAAVVQEEL RELAESWRAL RLLEESLLSL IRNWHLQRME VDSGKKMVFT NNIPKSGFLI
     NPMDPIPRHR RRANLLQEEE GSHEDFSQLL RNFGQWLQVE NSKLVRIIAM RTSTAEDLRT
     RKSKLQELEA RVPEGQHLFE NLLRLGPARG TSDELEDLRY QWMLYKSKLK DSGHLLTQSS
     PGEPTGFQKT RRWRGLGSLF RRACCVALPL QLLLLLFLLL LFLLPIREED RSCTLANNFA
     RSFTLMLRYN GPPPT
//
